3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Carcinoma, Hepatocellular
46
Liver Neoplasms
9
Neoplasm Metastasis
4
Leukemia, Myeloid, Acute
4
Pancreatic Neoplasms
3
Melanoma
3
Carcinoma, Renal Cell
3
Sarcoma
2
Recurrence
2
Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Carcinoma
2
Breast Neoplasms
2
Uveal Melanoma
1
Urinary Bladder Neoplasms
1
Testicular Neoplasms
1
Relapsed Pediatric Solid Tumor
1
Portal Vein Tumor Thrombus
1
Neoplasms, Glandular and Epithelial
1
Neoplasms, Germ Cell and Embryonal
1
Neoplasms by Site
1
Neoplasms by Histologic Type
1
Mesothelioma
1
Lung Neoplasms
1
Liver Diseases
1
Leukemia, Monocytic, Acute
1
Kidney Neoplasms
1
Hemangiosarcoma
1
HCC
1
Gastrointestinal Neoplasms
1
Interventions
Etoposide
4
Cisplatin
4
Ifosfamide
3
Filgrastim
3
Carboplatin
3
Bleomycin
3
pegfilgrastim
2
Paclitaxel
2
lerisetron
1
isophosphamide mustard
1
Watchful Waiting
1
Vinblastine
1
Surveys and Questionnaires
1
Sorafenib
1
Radiotherapy
1
Polymerase Chain Reaction
1
Peripheral Blood Stem Cell Transplantation
1
Olanzapine
1
Magnetic Resonance Spectroscopy
1
Lenograstim
1
Granisetron
1
Gemcitabine
1
Flow Cytometry
1
Drug Therapy
1
Dexamethasone
1
Chemotherapy, Adjuvant
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Testicular Neoplasms
×
Sorafenib
×
Clear all
NCT00772694
2008-10-24
GCT
Fondation Wygrajmy Zdrowie
Phase 2
Unknown
20 enrolled